Genky DrugStores Co., Ltd.

9267.T

9267.TGenky DrugStores Co., Ltd. JP flag

Tokyo Stock Exchange

4,120.00

JPY

-25.00

(-0.60%)

221.41EPS

18.61P/E

125.23BMarket Cap

Jul 28Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

JP3282750003

Return %

Stock

S&P500

45.38

14.32

138.49

59.99

127.94

93.51

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	2,062.28	1,983.05	1,048.54	2,260.78	2,608.52	2,956.98	3,141.9	3,364.32	4,071.98	4,690.45	5,093.66	5,567.39	- -	6,086.33
Basic EPS, GAAP	41.62	22.61	21.19	63.06	67.48	100.9	103.27	87.35	90.76	159.17	145.59	156.89	- -	208.21
Free Cash Flow per Basic Share	-34.65	-100.06	21.34	-58.04	-176.25	-43.04	2.49	-207.97	-118.42	102.81	-145.92	-38.04	- -	- -
Dividend per Share	6.23	6.25	3.13	6.88	7.53	8.73	12.21	12.52	12.5	12.5	12.48	12.48	- -	- -
Book Value per Share	252.16	267.9	151.91	357.91	414.93	506.65	561.73	624.05	713.16	872.34	1,005.93	1,150.2	- -	1,346.13
Tangible Book Value per Share	280.43	293.88	165.01	381.17	437.76	529.11	779.61	810.13	902.07	1,046.71	1,181.13	1,327.71	- -	1,524.41
Basic Weighted Avg Shares	27	28	55	28	28	28	30	31	30	30	30	30	- -	30
Sales/Revenue/Turnover	56,701	54,656	57,950	63,144	73,496	83,400	94,869	103,897	123,603	142,376	154,639	169,059	184,860	184,860
Operating Margin (%)	3.39	1.64	3.28	4.34	3.61	4.62	4.35	3.9	3.51	4.42	3.67	3.97	4.88	4.88
Depreciation Expense	1,173	1,356	1,454	1,553	2,189	2,614	2,910	3,320	3,761	4,059	4,592	4,955	5,566	- -
Net Income, GAAP	1,144	623	1,171	1,761	1,901	2,846	3,118	2,698	2,755	4,832	4,420	4,764	6,324	6,324
Effective Tax Rate (%)	44.37	38.72	41.27	38.02	33.68	30.42	28.14	30.59	31.67	27.48	27.34	28.92	28.15	28.15
Profit Margin (%)	2.02	1.14	2.02	2.79	2.59	3.41	3.29	2.6	2.23	3.39	2.86	2.82	3.42	3.42
Working Capital	-1,817	-1,380	-2,160	-4,663	-6,083	-5,631	-4,779	-2,946	319	-2,501	-6,133	-5,703	-3,512	-3,512
LT Debt	4,410	7,304	6,775	7,867	10,896	13,210	8,738	16,036	24,422	21,710	20,762	21,093	22,553	22,553
Total Equity	7,785	8,244	9,270	10,894	12,584	15,178	23,805	25,310	27,686	32,166	36,232	40,680	46,679	46,679
Return on Invested Capital (%)	8.04	3.39	5.88	7.87	6.58	8.19	8.05	6.47	5.53	7.55	6.34	6.71	8.45	8.45
Return on Capital (%)	9.88	4.39	6.89	9.08	7.73	9.3	9.78	7.57	5.99	9.1	7.66	7.48	9.22	9.22
Return on Common Equity (%)	17.76	8.7	14.84	19.15	17.53	21.91	19.96	14.89	13.47	20.08	15.5	14.55	16.68	16.68

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	12.35%	12.29%	9.35%
Net Income, GAAP	21.36%	21.9%	32.75%
Free Cash Flow	-974.87%	-178.09%	-343.72%
Total Cash Common Dividend	- -	- -	0.26%
Total Equity	18.21%	13.05%	14.75%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Kenichi Fujinaga
Full Time Employees: 1,661
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Address: 38-33, Shimokumeda Sakai Japan 910-0332
IPO Date: Feb 22, 2010
Website: genkydrugstores.co.jp
Similar Companies: Basilea Pharmaceutica AG (0QNA.L)
Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
Neuca S.a. (NEU.WA)
Rising BioSciences, Inc. (RBII)
Exelixis, Inc. (0IJO.L)
Denis Chem Lab Limited (DENISCHEM.BO)
Business: Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.

Year	Q1	Q2	Q3	Q4	FY
2022	39,118	37,123	37,525	40,873	154,639
2023	42,613	41,261	40,331	44,854	169,059
2024	46,871	45,096	44,620	48,273	184,860

Year	Q1	Q2	Q3	Q4	FY
2022	40.59	- -	- -	- -	145.59
2023	36.29	- -	- -	- -	156.89
2024	47.54	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	- -	- -	- -	- -	12.48
2023	- -	- -	- -	- -	12.48
2024	- -	- -	- -	- -	- -

	Dec'24	Mar'24	Jun'24
Total Current Assets	34,761	34,782	37,334
Accounts Receivable, Net	3,978	4,105	4,685
Cash, Cash Equivalents & STI	4,064	5,985	5,896
Inventories	23,973	22,273	24,028
Total Current Liabilities	37,636	35,838	40,846
Payables & Accruals	- -	- -	- -
ST Debt	8,330	7,916	8,095
Deferred Revenue	- -	- -	- -

	Dec'24	Mar'24	Jun'24
ST Debt	8,330	7,916	8,095
LT Borrowings	22,929	23,684	22,408
LT Finance Leases	- -	- -	145
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	30	30	30
Market Capitalization	82,558	99,493	87,355

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	2,062.28	1,983.05	1,048.54	2,260.78	2,608.52	2,956.98	3,141.9	3,364.32	4,071.98	4,690.45	5,093.66	5,567.39	- -	6,086.33
Basic EPS, GAAP	41.62	22.61	21.19	63.06	67.48	100.9	103.27	87.35	90.76	159.17	145.59	156.89	- -	208.21
Free Cash Flow per Basic Share	-34.65	-100.06	21.34	-58.04	-176.25	-43.04	2.49	-207.97	-118.42	102.81	-145.92	-38.04	- -	- -
Dividend per Share	6.23	6.25	3.13	6.88	7.53	8.73	12.21	12.52	12.5	12.5	12.48	12.48	- -	- -
Book Value per Share	252.16	267.9	151.91	357.91	414.93	506.65	561.73	624.05	713.16	872.34	1,005.93	1,150.2	- -	1,346.13
Tangible Book Value per Share	280.43	293.88	165.01	381.17	437.76	529.11	779.61	810.13	902.07	1,046.71	1,181.13	1,327.71	- -	1,524.41
Basic Weighted Avg Shares	27	28	55	28	28	28	30	31	30	30	30	30	- -	30
Sales/Revenue/Turnover	56,701	54,656	57,950	63,144	73,496	83,400	94,869	103,897	123,603	142,376	154,639	169,059	184,860	184,860
Operating Margin (%)	3.39	1.64	3.28	4.34	3.61	4.62	4.35	3.9	3.51	4.42	3.67	3.97	4.88	4.88
Depreciation Expense	1,173	1,356	1,454	1,553	2,189	2,614	2,910	3,320	3,761	4,059	4,592	4,955	5,566	- -
Net Income, GAAP	1,144	623	1,171	1,761	1,901	2,846	3,118	2,698	2,755	4,832	4,420	4,764	6,324	6,324
Effective Tax Rate (%)	44.37	38.72	41.27	38.02	33.68	30.42	28.14	30.59	31.67	27.48	27.34	28.92	28.15	28.15
Profit Margin (%)	2.02	1.14	2.02	2.79	2.59	3.41	3.29	2.6	2.23	3.39	2.86	2.82	3.42	3.42
Working Capital	-1,817	-1,380	-2,160	-4,663	-6,083	-5,631	-4,779	-2,946	319	-2,501	-6,133	-5,703	-3,512	-3,512
LT Debt	4,410	7,304	6,775	7,867	10,896	13,210	8,738	16,036	24,422	21,710	20,762	21,093	22,553	22,553
Total Equity	7,785	8,244	9,270	10,894	12,584	15,178	23,805	25,310	27,686	32,166	36,232	40,680	46,679	46,679
Return on Invested Capital (%)	8.04	3.39	5.88	7.87	6.58	8.19	8.05	6.47	5.53	7.55	6.34	6.71	8.45	8.45
Return on Capital (%)	9.88	4.39	6.89	9.08	7.73	9.3	9.78	7.57	5.99	9.1	7.66	7.48	9.22	9.22
Return on Common Equity (%)	17.76	8.7	14.84	19.15	17.53	21.91	19.96	14.89	13.47	20.08	15.5	14.55	16.68	16.68

Genky DrugStores Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Working Capital

Capital Structure